India launches major nanotech programme:
This article was originally published in Clinica
India is reportedly planning to invest Rs1,000 crore ($229m) to the Indian Institute of Science to fund a five-year nanotech manufacturing programme. One technology mooted to receive funds is a synchrotron facility, which produces X-rays and other radiation. The "national mission on nano science and nano technology" has been launched by the department of science and technology (DST), which has spent between Rs20m-30m per year for the past three years on fostering research in nanotechnology. The Hindu reports that the pledge follows a grant of Rs100 crore to make the institute a world class institution.
You may also be interested in...
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.
US Vice President Mike Pence and Medicare administrator Seema Verma want academic and university hospital laboratories to send their de-identified COVID-19 test data results, daily, to the Department of Health and Human Services. Commercial and private labs are exempt from the request, as they already share their coronavirus test results with the government.